Owkin
Diane Chisholm currently serves as the Head of Global Clinical Operations at Owkin since March 2024. Prior to this role, Diane held several significant positions including Head of Clinical Operations and Senior Director of Clinical Operations at Blue Earth Diagnostics from September 2017 to October 2023. Previous experience also includes Director of Clinical Operations at Fujifilm Kyowa Kirin Biologics Co Ltd and Head of Clinical Operations at Santhera Pharmaceuticals Ltd. Additionally, Diane worked as a Freelance Pharmaceutical Consultant at Tannith Research Services and as Senior Director of Late Phase Global Project Management at Quintiles. Diane began a career in clinical operations as Vice President of Project Management at Omnicare Clinical Research and served as Outsourcing Manager at Novartis Pharmaceutical AG. Diane holds a Bachelor of Arts in Biology and Psychology from Keele University, completed in 1979.
This person is not in any teams
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.